Exhibit 99.1 ◾ Contact: Trinity Biotech plc LifeSci Partners, LLC Louise Tallon Eric Ribner (353)-1-2769800 (1)-646-751-4363 investorrelations@trinitybiotech.com RedChip Companies Inc. Dave Gentry, CEO (1)-407-644-4256 TRIB@redchip.com Trinity Biotech Announces Q3 2024 Financial Results Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% Y/Y Reiterates guidance to achieve approximately $20 ...